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Early outcomes after elective and emergent
endovascular repair of the thoracic aorta
Vikram S. Iyer, MD, Kent S. MacKenzie, MD, Leonard W. Tse, MD, Cherrie Z. Abraham, MD,
Marc-Michel Corriveau, MD, Daniel I. Obrand, MD, andOren K. Steinmetz, MD,Montréal, Québec, Canada
Background: Endovascular treatment of thoracic aortic pathology has emerged as a viable alternative to open surgical
repair in both the elective and emergent settings. The aim of this study was to evaluate preoperative work-up,
intra-operative strategy, and outcomes of endovascular stent-grafting of the thoracic aorta in patients undergoing elective
repair and those undergoing emergent repair.
Methods: All patient information was obtained by a retrospective review of an established clinical database for all
endovascular thoracic stent-graft cases. From October 1999 to August 2005, 70 patients were treated with endovascular
stent-grafts for lesions of the thoracic aorta. Thirty-five patients had an elective endovascular procedure, and 35 patients
had an emergent procedure.
Results: Thirty-five patients in the endovascular (EL) group were treated for aneurysm (n  34) and type B dissection
(n  1). Thirty-five patients in the emergent (EM) group were treated for aneurysm (n  10), intramural hematoma
(n  10), type B dissection (n  7), traumatic rupture (n  7), and aortoesophageal fistula (n  1). Preoperative
angiography was performed in 94.3% (33/35) of EL patients but in only 45.7% (16/35) EM patients (P < .005). The
EM procedures had significantly shorter operative times, used lower contrast volumes, used fewer stent-graft components
(mode 2, range 1 to 5 vs mode 1, range 1 to 3; P  .02), and spinal cerebrospinal fluid drains were used significantly less
often (82.9% vs 57.1%, P  .04). Both groups had similar 30-day morbidity, mortality (0/35 EL vs 1/35 [2.9%] EM,
P  .99), postoperative endoleak (9/35 [25.7%] EL vs 7/35 [20.0%] EM, P  .78), endovascular failure (3/35 [8.6%]
EL vs 5/35 [14.3%] EM, P  .71), and patient survival.
Conclusion: There are significant differences in the underlying pathology, preoperative evaluation, and operative course
between elective and emergency treatment endovascular procedures for lesions of the thoracic aorta. Endovascular repair
of thoracic aortic lesions can be accomplished with low perioperative mortality and morbidity rates, as well as acceptable
endoleak and endovascular failure rates for both elective and emergency procedures. ( J Vasc Surg 2006;43:677-83.)Despite some improvement in the last decade, the
operative mortality of conventional surgery for thoracic
aortic pathology is significant1 and even higher for thoracic
aortic emergencies.1-4 Endovascular stent-grafting of the
thoracic aorta appears favorable in certain circumstances.5-9
These apparent improved results with endografting have
made it a viable option in both elective and emergent
settings.
At our institution, we started treating patients with
endografts in May 1999. Endovascular repair for abdomi-
nal and thoracic aortic lesions was initially limited to pa-
tients deemed to be at high or prohibitive risk for open
surgery. As our experience with the techniques has grown
over time, we have gradually liberalized our indications for
endovascular treatment. Currently for lesions in the tho-
racic aorta, all patients with suitable anatomy would be
considered candidates for endovascular repair. At our insti-
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doi:10.1016/j.jvs.2005.12.001tution, 10% of endovascular infrarenal abdominal aortic
aneurysm (AAA) repairs are performed in the emergent
setting. In contrast, 50% of the thoracic endografts are
placed emergently. The aim of this study was to evaluate the
preoperative work-up, intra-operative strategy, and out-
comes of endovascular stent-grafting of the thoracic aorta
in patients undergoing elective repair and those undergo-
ing emergent repair.
MATERIALS AND METHODS
Data from our institutional database for thoracic endo-
vascular procedures were reviewed for this study. All pa-
tients who were treated with thoracic aortic endovascular
stent-grafts were included for analysis. For the purposes of
this study, patients were placed in an elective (EL) group if
the procedure was a planned intervention after outpatient
evaluation or in the emergent (EM) group if the procedure
was required for an urgent indication performed within the
same hospital admission and with endovascular stent-grafts
available on site. In the EM group, 30 (86%) of 35 patients
were transported to the operating room from the intensive
care unit. Only two patients were so unstable that they
were transported directly from the emergency department
to the operating room, and three patients were transported
to the operating room from a hospital ward.
All procedures were performed in the operating room
by using portable C-arm fluoroscopy (Philips BV300,
Andover, Mass or OEC 9800, GE Medical Systems, Mil-
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65) (Medtronic AVE, Santa Rosa, Calif) or Zenith (n 5)
(William Cook, Bjaeverskov, Denmark) self-expanding tho-
racic endografts. The grafts were oversized by 15% to 20%
with respect to aortic diameter, and the proximal diameters
were 26 to 46mm.Whenmore than one graft was used, we
attempted to obtain an overlap of at least 4 to 5 cm between
components.
Access for graft delivery was through the common
femoral artery, iliac artery via retroperitoneal exposure, or
aorta via laparotomy. A catheter used for angiography
during graft deployment was placed through the contralat-
eral femoral artery or the right brachial artery. All but one
patient received systemic heparin during graft delivery, and
pharmacologic hypotension was induced at the time of
deployment.
Intraoperative digital subtraction angiography (DSA)
runs were performed at the completion of each procedure
to assess for endoleaks and branch patency. A staged supra-
clavicular extra-anatomic bypass to revascularize the aortic
arch vessels and extend the proximal landing zone was
performed routinely for zone 1 and selectively for zone 2
repairs, as described by Tse et al.10
All patients were followed postoperatively with a com-
puted tomography (CT) scan 1 month and then at
6-month intervals. We reviewed (1) preoperative variables
of diagnostic imaging, patient characteristics, and indica-
tions for treatment, (2) procedural variables, and (3) out-
comes of morbidity, postoperative (30 days) and late
(30 days) mortality, endoleak, secondary intervention
rates, and endograft failure. We defined endograft failure as
the presence of early or late endoleak requiring treatment
not salvageable by subsequent endovascular therapy, the
requirement for open conversion, or graft-related death.
These variables were compared between the emergency and
elective groups.
Statistical analysis was performed with the MedCalc
5.00 (Frank Schoonjans) and SPSS 13.0 statistical software
programs (SPSS Inc, Chicago, Ill). The 2 test was used for
categoric variables and the t test for continuous variables.
Kaplan-Meier survival analysis was performed for mortality,
secondary intervention, and endograft failure. The log-rank
test was used for statistical comparison.
RESULTS
Patient variables. From October 1999 to August
2005, 70 patients were treated with endovascular stent-
grafts for lesions of the thoracic aorta. Thirty-five patients
had an EL endovascular procedure and 35 patients had an
EM procedure. Mean patient ages were 72.3 years (range,
36 to 89 years) for EL patients and 67.5 years (range, 29 to
95 years) for EM patients.
The indications for intervention are listed in Table I.
Thoracic aortic aneurysm was the dominant indication in
the EL group (34/35). The etiology of these aneurysms
was atherosclerosis in 32, secondary to chronic type B
dissection in one, and chronic post-traumatic pseudoaneu-rysm in one. One chronic type B dissection caused distal
visceral embolization.
In the EM group, thoracic aortic aneurysm was much
less common (10/35); of these, four were symptomatic,
three presented with contained rupture, one had an aortoe-
sophageal fistula and rupture, and two were mycotic and
symptomatic. Seven acute type B dissections refractory to
medical therapy also occurred; of those, six had persistent
pain, poorly controlled blood pressure, and aneurysm for-
mation, and one patient had persistent pain and hyperten-
sion. Ten patients in the EM group had acute intramural
hematomas refractory to medical therapy, of which six had
intractable pain and poorly controlled hypertension and
four had intractable pain, poorly controlled hypertension,
and aortic dilation. There were seven traumatic aortic rup-
tures, and one aortoesophageal fistula associated with be-
nign esophagitis.
The mean time between presentation to hospital and
operation in the EM group was 4.7 days (range, 0 to 31
days), with 5.7 days (range, 0 to 28 days) for aneurysms;
4.6 days (range, 1 to 8 days) for acute dissections; 3.3 days
(range, 0 to 12 days) for intramural hematomas; 6.8 days
(range, 0 to 31) for traumatic aortic ruptures, and 0 days for
aortoesophageal fistula.
The preoperative patient characteristics of both groups
are summarized in Table II. Significantly more patients had
an American Society of Anesthesiologists score of4 in the
EM group (20/35 [57.1%]) than in the EL group (10/35
[28.6%]) (P  .03).
Preoperative imaging. All patients were evaluated
preoperatively with intravenous contrast-enhanced com-
puted tomography (CT) scans using 1.5- to 3-mm slice
intervals. CT reconstructions were performed selectively to
Table I. Indications for thoracic endografting
Indication
Elective
n (%)
Emergent
n (%)
Total
n (%)
Aneurysma 34 (97.1)b 10 (28.6)c 43 (61.4)
Dissection 1 (2.9)d 7 (20.0)e 8 (11.4)
Intramural hematoma 0 10 (28.6)f 10 (14.3)
Acute traumatic aortic
transection 0 7 (20.0) 7 (10.0)
Aortoesophageal fistula
(without aneurysm) 0 1 (2.9)g 1 (1.4)
Total 35 35 70
aMean diameter, 61.4 mm; range, 50 to 80 mm.
bThirty-three atherosclerotic aneurysms, 1 secondary to chronic type B
dissection, and 1 chronic post-traumatic pseudoaneurysm.
cFour atherosclerotic symptomatic, 3 atherosclerotic with contained rup-
ture, 1 atherosclerotic with aortoesophageal fistula and rupture, and 2
mycotic.
dChronic type B dissection with embolic source from aortic false lumen.
eSix acute type B dissections refractory to medical therapy with aneurysm
formation, and 1 acute type B dissection refractory to medical therapy
without aneurysm
fSix with intractable pain and poorly controlled hypertension, 4 associated
with aortic dilation.
gAssociated with reflux esophagitis and stricture.evaluate the relationship between the proximal landing
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evaluate the proximity to the visceral vessels in distal le-
sions. A preoperative angiogram with graduated catheter
for confirmation of diameter and length measurements was
obtained in 33 (94.3%) of 35 EL patients but in only 16
(45.7%) of the 35 EM patients (P  .0005). Four patients
in the EM group were examined with transesophageal
echocardiography (TEE).
Comparison of procedural variables. The intraoper-
ative variables are summarized in Table III. No statistically
significant differences were seen in the use of planned or
unplanned conduits, extra-anatomic bypasses, general an-
esthesia, or adenosine for cardiac standstill. A higher pro-
portion of EL patients (82.9%) had a spinal cerebrospinal
fluid (CSF) drain placed than did EMpatients (57.1%) (P
0.04). The EL group had, respectively, a higher mode
number of stent-graft components (2 vs 1, P .02), mean
volume (mL) of iodinated contrast (145 [40 to 350] vs 108
[20 to 310], P  .03), and longer mean operative time in
minutes (184 [75 to 330] vs 153 [75 to 260] P .03) than
the EM group.
Mortality. Thirty-day mortality was zero in the EL
group and one (2.9%) in the EM group (P  .99). The
single death occurred intraoperatively in a patient with a
ruptured thoracic aortic aneurysm and aortoesophageal
fistula. Late deaths occurred in 31.4% (11/35) of EL
patients and in 22.9% (8/35) of EM patients (P  .60).
These were graft related in two (5.7%) EL patients, both
after atherosclerotic aneurysm repair. One patient died
from stroke after secondary intervention to treat an en-
doleak 3 months after the initial procedure. The other died
from sepsis after drainage of a perigraft abscess secondary to
an aortoesophageal fistula 27 months after the initial pro-
cedure. The nine deaths in the EL group that were not
Table II. Preoperative patient characteristics
Factor
Elective
n (%)
Emergent
n (%) P
Mean age, years (range) 72.2 (36-89) 66.1 (21-95) .09
Male 17 (48.6) 20 (57.1) .64
Previous aneurysm repair 14 (40.0)a 7 (20.0)b .12
Diabetes mellitus 4 (11.4) 6 (17.1) .74
Hypertension 27 (77.1) 22 (62.9) .30
Smoker in last 2 years 14 (40.0) 15 (42.9) .99
COPD 10 (28.6) 8 (22.9) .79
Previous stroke 4 (11.4) 2 (5.7) .67
History of cardiac disease 15 (47.1) 12 (35.3) .45
Preoperative renal failurec 7 (20.0) 5 (14.3) .76
ASA score 3 10 (28.6) 20 (57.1) .03
COPD, Chronic obstructive pulmonary disease; ASA, American Society of
Anesthesiologists.
aEleven open repairs for infrarenal abdominal aortic aneurysm (AAA), 2 for
thoracoabdominal aortic aneurysm, and 1 for thoracic aortic aneurysm
(TAA) as well as one previous emergent endovascular TAA repair at a
different site in the thoracic aorta.
bSix open repairs for infrarenal AAA, and 1 endovascular iliac aneurysm
repair.
cSerum creatinine 110 mol/L.related to the endograft were cardiac in four, respiratory intwo, and one death each from cancer-related causes, sepsis,
and an untreated ruptured AAA.
A late graft-related death occurred in one EM patient
(2.9%) due to late aneurysm rupture from a type Ia en-
doleak 3 months after a zone 1 repair. The seven deaths
unrelated to the endograft were from sepsis in four, and one
death each from myocardial infarct, stroke, and an un-
known cause. Survival is plotted with respect to time in
F i g 1 . The two groups did not differ statistically (P  .63).
Morbidity. Table IV summarizes the 30-day postop-
erative complications. There were 20 significant postoper-
ative complications in seven (20.0%) of the 35 EL patients
and 32 complications in 14 (40.0%) of the 35 EM patients
(P  .12). No cases of spinal cord ischemia occurred in
either group.
Endoleaks, secondary interventions, and endograft
failure. Table V summarizes endoleaks, secondary inter-
ventions, and endograft failure. Postoperative endoleaks
occurred in 25.7% (9/35) of EL patients and in 20.0%
(7/35) of the EM patients (P  .78). Secondary endovas-
cular interventions were performed in six patients (17.1%)
Table III. Procedural variables
Procedure or factor
Elective
n (%)
Emergent
n (%) P
Planned adjunctive 7 (20.0)a 5 (14.3)b 0.76
Unplanned adjunctive
procedure 6 (17.1)c 7 (20.0)d 0.99
Cervical Extra-anatomic
bypasse 5 (14.3) 1 (2.9) 0.2
General anesthesia 34 (97.1) 34 (97.1) 0.48
Spinal CSF drain 29 (82.9) 20 (57.1) 0.04
Adenosine-induced cardiac
standstill for graft
deployment 11 (31.4) 7 (20.0) 0.41
Number of stent-graft
components, mode
(range) 2 (1-5) 1 (1-3) 0.02
Mean iodinated contrast
Used (mL) (range) 144 (40-350) 109 (20-310) 0.03
Mean operative time (min)
(range) 184 (75-330) 151 (75-260) 0.03
Zone of repairf
1 2 1 0.99
2 6 5 0.99
3 9 11 0.79
4 18 18 0.81
aFive iliac artery, 2 aortic Dacron conduits.
bThree iliac artery, 2 aortic Dacron conduits.
cThree iliofemoral bypasses, 1 femoral artery repair, 1 brachial artery repair,
and 1 extra-anatomical cervical bypass for inadvertent coverage of left
common carotid artery.
dThree iliofemoral bypasses, 4 femoral artery repairs.
eSupraclavicular bypass to extend proximal landing zone as described by Tse
et al.10
fRefers to position of the proximal edge of the endograft within the aortic
arch. Zone 0 is proximal to the innominate artery, zone 1 is distal to the
innominate artery, zone 2 is distal to the left common carotid artery, zone 3
is2 cm distal to the left subclavian artery, and zone 4 is2 cm distal to the
left subclavian artery.in each group and were successful in four (66.7%) of six for
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one (2.9%) EL patient and two (5.7%) EM patients (P 
.99). Not all endoleaks were treated. One EM patient
refused treatment for a type I endoleak, and two EL pa-
tients are being followed for type II endoleaks without
aneurysm expansion. Endovascular failure occurred in
three (8.6%) EL and five (14.3%) EM patients (P  .71).
Freedom from secondary interventions and freedom from
endograft failure are represented in Figs 2 and 3, respec-
tively.
DISCUSSION
The reported perioperative mortality rates for elective
open surgery for thoracic aortic lesions such as aneurysms
and chronic dissections range from 0% to 31%, with para-
plegia rates between 0% and 50%.11 The perioperative
mortality risk rises significantly after emergent surgery for
Fig 1. Survival after thoracic endograft placement in elective and
emergent groups. There was no significant difference between the
groups (Kaplan-Meier, log-rank test, P  .63). The arrows and
········ (elective) and ··—··—·· (emergent) lines depict standard
error of 10%.
Table IV. Thirty-day postoperative complications in
7 (20%) elective and 14 (40%) emergent patients
Complication
Elective
n (%)
Emergent
n (%) P
Stroke 3 (8.6) 2 (5.7) .99
Spinal cord ischemia 0 0 —
Cardiaca 6 (17.1) 5 (14.3) .99
Pulmonary embolus 1 (2.9) 1 (2.9) .48
Respiratoryb 2 (5.7) 6 (17.1) .27
Acute renal failure 1 (2.9) 2 (5.7) .99
Wound hematoma 1 (2.9) 3 (8.6) .61
Wound infection 1 (2.9) 0 .99
Peripheral neurapraxia 1 (2.9) 0 .90
Intraoperative arterial injury 5 (14.3) 7 (20.0) 0.76
Mortality 0 1 (2.9) 0.99
aIncludes arrhythmia, myocardial infarct, and heart failure.
bIncludes pneumonia and prolonged ventilation.lesions of the descending thoracic aorta, and is reported tobe 15% to 26% for ruptured aortic aneurysms,4,12-14 39%
for repair of acute aortic dissections of the descending
thoracic aorta,3 and up to 29% for the repair of acute post
traumatic pseudoaneurysms or transections of the thoracic
aorta5 in high-volume centers. In contrast, initial reports
for elective endovascular stent-graft repair of thoracic aortic
lesions have demonstrated comparatively low perioperative
Table V. Endoleaks, secondary interventions and
endovascular failure
Incidence
Elective
n (%)
Emergent
n (%) P
Endoleaks 9 (25.7)a 7 (20.0)b .78
Endovascular interventions 6 (17.1)c 6 (17.1)d .76
Conversions 1 (2.9)e 2 (5.7)f .99
Endovascular failure 3 (8.6)g 5 (14.3)h .71
aThree type Ia, 3 type Ib, and 3 type II.
bThree type Ia, 2 type Ib, 1 type III, and 1 type V.
cTwo proximal extensions, 2 distal extensions, and 2 coil embolizations.
dOne proximal extension, 3 distal extensions, and 2 endograft deployments
to treat junction leaks.
eOne type Ia endoleak after zone 1 repair for thoracic aortic aneurysm (TAA)
was successfully converted to open repair with explantation of stent-graft.
fOne type Ia endoleak after repair for acute type B dissection unsuccessfully
treated with proximal extension graft, successfully converted; 1 mycotic
aneurysm developed an aortobronchial fistula and was successfully converted
to open repair.
gOne open conversion survived; 1 type Ia endoleak treated with proximal
extension and carotid-carotid bypass for zone I extension of proximal
landing zone, complicated by stroke and death; 1 type Ib endoleak causing
aneurysm enlargement and aortoesophageal fistula, treated with distal ex-
tension but complicated by delayed sepsis and death.
hTwo open conversions survived; 1 intraoperative death from TAA rupture;
1 rupture and death from a type Ia endoleak 3 months after a zone 1 repair
for TAA; 1 type Ia endoleak 3 months after treatment for acute type B
dissection, treatment refused.
Fig 2. Freedom from secondary endovascular interventions or
conversions in elective and emergent groups. There was no signif-
icant difference between the groups (Kaplan-Meier, log-rank test,
P .75). The arrows and ········ (elective) and— — — (emergent)
lines depict a standard error of 10%.mortality and morbidity rates,15-17 and many have reported
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ment.18-21
In this study, we found that half of our thoracic endo-
vascular cases were performed emergently. We evaluated
both emergent and elective endovascular procedures with
respect to preoperative and operative variables as well as
outcomes. We found major differences in operative indica-
tions between the two groups. Nearly all of the elective
cases were performed for atherosclerotic thoracic aortic
aneurysm, whereas the underlying pathology in the emer-
gent group comprised a wide range of pathology, including
ruptured and symptomatic aneurysms, acute aortic dissec-
tion, acute intramural hematomas, aortic traumas, and
aortoesophageal fistula.
Acute aortic dissection and acute intramural hemato-
mas accounted for nearly half of the emergent cases. During
the time of this series, our indications for treatment of
patients with acute dissections and intramural hematomas
with an endovascular stent-graft were the same as our
indications for open surgery in this group of patients,
including persistent symptoms despite medical therapy,
end-organ ischemia, acute aneurysm formation, and aortic
rupture.17,22 Our strategy has been to cover the proximal
entry tear in dissections and hematomas in which an entry
tear is identified. We have not tried to stent the entire
dissected aorta in these patients. Our indications for stent-
graft treatment during this time period differ significantly
from the trend demonstrated in the latest report from
the EUROSTAR and UK Thoracic Endograft registry,23
where 43% of type B aortic dissection patients were asymp-
tomatic and treated with stent-grafts to prevent late aneu-
rysm formation, an indication that may or may not be
validated by future trials.24
Acute intramural hematoma was the indication for
Fig 3. Freedom from endovascular failure in elective and emer-
gent groups. There was no significant difference between the
groups (Kaplan-Meier, log-rank test, P  .41). The arrows and
········ (elective) and ··—··—·· (emergent) lines depict a standard
error of 10%.treatment in 28.6% of the patients in our emergent group.This is consistent with recent literature reports, where acute
intramural hematoma represents 10% to 30% of all nontrau-
matic acute aortic syndromes. Modern imaging capabilities
have greatly improved the diagnosis and aided our under-
standing of its clinical significance.25,26 A recent study has
demonstrated that the most frequent long-term evolution
of intramural hematoma is one of aneurysm formation, and
only one third of patients will have complete regression
without treatment. This study revealed that normal aortic
diameter was an independent predictor of intramural he-
matoma regression without complications and that all pa-
tients with persistent pain did not evolve favorably. Patients
with persistent pain evolved towards aortic dissection or
aneurysmal formation.27
During the study period, all patients in the EL group
had a preoperative CT scan with intravenous contrast en-
hancement, and most had a preoperative aortography with
graduated catheter for determination of intravascular length
measurements. In the EM cases, a preoperative CT scan
with contrast was performed in all patients, but less than
half the cases had preoperative aortography. In the EM
patients, the selection of the number, diameter, and length
of endograft components was based on axial CT scans and
three-dimensional reconstructions and then confirmed in-
traoperatively with a calibrated angiographic catheter in
select cases.
Our study found no difference in the number of en-
doleaks and graft-related adverse outcomes between the
EM and EL groups, and only a few EM patients had preop-
erative contrast angiography. From these findings, we cur-
rently believe that preoperative arteriography with a grad-
uated catheter is not routinely required for elective and
emergent cases. We used TEE primarily for the assessment
of the proximal extent of aortic dissections and intramural
hematomas and only infrequently as a preoperative diag-
nostic modality for graft selection.
There were significant differences in the number of
stent-graft components used, amount of contrast used, and
operative time between the EM and EL groups. Many of
these differences can be explained by the difference in
pathology between the two groups. To successfully exclude
an aneurysm of the thoracic aorta, the endograft must span
the entire length of the lesion with adequate fixation points
proximal and distal to the pathology.
In contrast to the emergent conditions treated in this
series, chronic atherosclerotic aneurysms are relatively long
lesions and required longer segments of aortic coverage to
achieve secure exclusion of the lesions by the stent-grafts.
Endovascular treatment of acute dissections, acute intra-
mural hematoma, and acute traumatic aortic injuries—the
predominant lesions found in the EM group—required
shorter lengths of aortic coverage and therefore fewer graft
components were required in the EM group. These find-
ings are supported in the recently reported European/UK
registries,22 where 69% of patients treated for dissection,
anastomotic aneurysm, or traumatic rupture had one en-
dograft component used compared with only 34% of those
treated for atherosclerotic aneurysms of the descending
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in the repair, the operative times will be shorter and fewer
intraoperative angiographies will be needed.
Significantly fewer spinal CSF drains were inserted be-
fore the procedure in EM patients compared with EL
patients (82.9% vs 57.1%). A recent meta-analysis28 sug-
gests a benefit for spinal CSF drainage to prevent paraplegia
in open repair of thoracic aortic aneurysms. Its use has not
been similarly evaluated in thoracic endovascular repair;
however, the incidence of paraplegia appears to be lower in
many reports of thoracic endografting.23,29,30 Possible risk
factors for paraplegia after endografting include periopera-
tive hypotension, length of aortic coverage, and previous or
concurrent abdominal aortic aneurysm repair.30-32
We used CSF drainage in most EL patients. The deci-
sion to omit CSF drainage in the EL patients was usually
made by the anesthetist in the presence of morphologic
limitations or previous spinal instrumentation. CSF drain-
age was used significantly less in the EM patients. One
reason for this could be that the length of aortic coverage
necessary to treat these EM patients was shorter, the prev-
alence of previous abdominal aortic surgery was lower, and
these patients were therefore considered at lower risk for
paraplegia. As well, five of the six patients treated for acute
traumatic aortic rupture in the emergent group did not
have a CSF drain. These trauma patients also had other
injuries, such as pelvic fractures, intra-abdominal injuries,
and closed head injuries, that made placement of a spinal
drain logistically difficult, and in some cases, contraindi-
cated. Paraplegia did not occur in either group, despite a
significant difference in the rate of CSF drain placement.
The overall endoleak rate was similar in the EL and EM
groups and comparable with other reported endoleak rates
after endovascular repair of thoracic aortic lesions.33,34 This
finding is supported in other reports where the proximal
landing zone was more of a factor determining endoleak
rate than was indication or urgency of the procedure.10
Type 2 endoleaks have rarely been a problem after thoracic
endografting,35,36 for unclear reasons. We identified three
cases of type 2 endoleak in this series (0 EM, 3 EL), of
which one required treatment. The other two patients with
type 2 endoleaks are being followed, with no evidence of
aneurysm expansion. With the use of secondary endovas-
cular interventions, acceptably low rates of endograft failure
were obtained in both groups.
We found low 30-day mortality rates in both elective
and emergent patients, 0% in the EL group and 2.9% in
the groups. This differs from other reports on thoracic
endografting, where higher perioperative mortality rates
are reported for emergent thoracic endovascular proce-
dures.23,37 In one study,23 this difference was more notice-
able for emergent aneurysm repair than for aortic dissec-
tion. The definition of emergent repair is not available from
this large registry, making it hard to draw any direct com-
parisons to the present study. In other small series, mortal-
ity rates of 0% for emergent thoracic endografting have
been reported,20,21 even when as many as 26% of patients
were treated for contained or free rupture of a thoracicaortic aneurysm. These and our results suggest an early
advantage of endografting for treatment of ruptured tho-
racic aortic aneurysms,4,12-14 acute aortic dissections,2,3
and acute thoracic aortic trauma,5 which have conventional
perioperative mortality rates of 15% to 29%.
The patient populations comprising the elective and
the emergent patient groups in our series are very different,
and the long-term survival of these patients will likely
depend largely on underlying pathology and comorbidity.
Other reports have demonstrated actuarial 5-year survival
of 48% to 59% after open surgery for type B dissection3 and
recent reports of 3-year survival of 50% to 70% after surgery
for thoracic aortic aneurysm and aortic dissection.1 The
follow-up period for our population is inadequate to eval-
uate patient survival beyond 2 years, but patient survival by
Kaplan-Meier analysis at 2 years was 70% for both the
emergent and elective patients in our series.
CONCLUSION
The preoperative and operative differences between
elective and emergent patients undergoing endovascular
treatment of thoracic aortic pathology are largely related to
the differences in pathologies seen in these two patient
populations. Despite these differences, endovascular repair
of thoracic aortic lesions can be accomplished with low
perioperative mortality and morbidity rates, and acceptable
endoleak, and endovascular failure rates for both elective
and emergent procedures.
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